BRIEF published on 11/13/2025 at 18:02, 1 month 4 days ago Heights Capital Management crosses thresholds Convertible Bonds Crossing Thresholds Shares And Voting Rights GenSight Biologics Heights Capital
BRIEF published on 11/13/2025 at 18:02, 1 month 4 days ago Franchissement de seuils par Heights Capital Management Obligations Convertibles Franchissement De Seuils GenSight Biologics Actions Et Droits De Vote Heights Capital
PRESS RELEASE published on 11/13/2025 at 17:57, 1 month 4 days ago Franchissement de seuils Déclaration de franchissement de seuils par Heights Capital Management pour le compte de CVI Investments, Inc. concernant GENSIGHT BIOLOGICS S.A. sur Euronext Paris Euronext Paris Franchissement De Seuils GENSIGHT BIOLOGICS SA Heights Capital Management CVI Investments Inc.
BRIEF published on 10/30/2025 at 07:35, 1 month 19 days ago GenSight Biologics: Green light for compassionate treatment in the United States FDA GenSight Biologics NOHL Compassionate Access GS010/LUMEVOQ®
BRIEF published on 10/30/2025 at 07:35, 1 month 19 days ago GenSight Biologics : Feu vert pour un traitement compassionnel aux États-Unis FDA GenSight Biologics NOHL Accès Compassionnel GS010/LUMEVOQ®
PRESS RELEASE published on 10/30/2025 at 07:30, 1 month 19 days ago Informations privilégiées / Autres communiqués GenSight Biologics a obtenu les autorisations réglementaires pour un traitement compassionnel aux États-Unis avec GS010/LUMEVOQ, visant la Neuropathie Optique Héréditaire de Leber FDA GenSight Biologics Neuropathie Optique Héréditaire De Leber GS010/LUMEVOQ Traitement Compassionnel
BRIEF published on 09/29/2025 at 23:05, 2 months 18 days ago GenSight Biologics Announces First Half 2025 Financial Results Financial Results Research And Development Treasury GenSight Biologics Early Access Programs
BRIEF published on 09/29/2025 at 23:05, 2 months 18 days ago GenSight Biologics annonce ses résultats financiers du premier semestre 2025 Résultats Financiers Recherche Et Développement Trésorerie GenSight Biologics Programmes D'accès Précoce
PRESS RELEASE published on 09/29/2025 at 23:00, 2 months 18 days ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie résultats financiers du premier semestre 2025 : gestion optimisée de trésorerie, financement post-clôture, transfert de fabrication, protocole d'étude soumis à l'ANSM Résultats Financiers Financement Trésorerie GenSight Biologics Étude ANSM
PRESS RELEASE published on 09/29/2025 at 23:00, 2 months 18 days ago Inside Information / News release on accounts, results GenSight Biologics reports 8.3% reduction in operating cash outflow and extends cash runway to late Q4 2025. Company's financial results show decrease in operating income, R&D expenses, and net cash flows Financial Results Operating Income Cash Management GenSight Biologics R&D Expenses
Published on 12/18/2025 at 06:25, 5 hours 9 minutes ago 1933 Industries Announces Maturity of Unsecured Convertible Debentures and Encourages Conversion to Support Continued Growth
Published on 12/18/2025 at 00:55, 10 hours 39 minutes ago Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 11 hours 34 minutes ago Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 12 hours 19 minutes ago Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 20 hours 34 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/18/2025 at 11:00, 34 minutes ago ABB Ltd: ABB share buybacks - December 11, 2025 - December 17, 2025
Published on 12/18/2025 at 11:00, 34 minutes ago BIRKENSTOCK REPORTS FISCAL 2025 REVENUE GROWTH AHEAD OF TARGET, OUTPERFORMING ADJUSTED EBITDA AND EARNINGS GROWTH; SETS FISCAL 2026 TARGETS
Published on 12/18/2025 at 10:47, 47 minutes ago Blue Cap AG with broadened investor base: Major shareholder PartnerFonds AG i.L. publishes results of share exchange offer
Published on 12/18/2025 at 10:45, 49 minutes ago Real Range on Real Road: Farizon SV Demonstrates World-Class Performance with Real-World Range Proof
Published on 12/18/2025 at 10:38, 56 minutes ago EQS-Adhoc: Blue Cap AG: Major shareholder PartnerFonds AG i.L. publishes the results of its share exchange offer
Published on 12/18/2025 at 10:00, 1 hour 34 minutes ago Neoen remporte 124 MWc de projets solaires en France
Published on 12/17/2025 at 20:39, 14 hours 55 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 14 hours 55 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 16 hours 4 minutes ago Evolution de la composition du Conseil d’Administration
